Flyte, Inc., the regional air mobility subsidiary of Catheter Precision, Inc. (VTAK), announced a strategic partnership with LifeVac to equip its fleet of Cirrus Vision Jets with LifeVac's airway clearance device for choking emergencies.
The partnership extends Flyte's safety program from the flight deck into the cabin, ensuring each aircraft is prepared for medical emergencies as well as aviation ones. LifeVac is the first and only suction anti-choking device to receive FDA De Novo authorization, cleared as a second-line treatment after standard choking-rescue protocols. It is non-powered, non-invasive and single-use, and has been credited in more than 6,200 reported choking rescues worldwide.
Placing LifeVac devices on every aircraft provides crews with an additional tool to respond to in-flight choking incidents, where outside help is not available.
Flyte's broader safety ecosystem integrates multiple layers of protection, including the Cirrus Airframe Parachute System (CAPS), Safe Return Emergency Autoland technology, advanced Garmin flight deck systems, and a standardized fleet built entirely around the Vision Jet to reduce operational variables.
"Safety isn't one feature. It's a system, and it's our foundation," said Marc Sellouk, Founder of Flyte. Arthur Lih, Founder and Chief Executive Officer of LifeVac added that "pairing LifeVac's life-saving airway clearance technology with the Vision Jet's industry-leading safety systems, we're helping create one of the most comprehensive safety platforms in the skies."
VTAK has traded between $0.61 and $4.94 over the past year. The stock closed Wednesday's trading at $1.37, up 92.23%. During overnight trading, the stock is at $1.13, down 17.52%.
For comments and feedback contact: editorial@rttnews.com
Economic News
What parts of the world are seeing the best (and worst) economic performances lately? Click here to check out our Econ Scorecard and find out! See up-to-the-moment rankings for the best and worst performers in GDP, unemployment rate, inflation and much more.
September 04, 2026 15:08 ET The job report and foreign trade data were the main economic news from the U.S. in the first week of September. Elsewhere in North America, the Canadian central bank announced its latest policy decision. Inflation data from Eurozone was the highlight in Europe. The latest interest rate decision by the Reserve Bank of New Zealand drew attention in Asia.